Standout Papers

Bosentan Therapy for Pulmonary Arterial Hypertension 1996 2026 2006 2016 1.9k
  1. Bosentan Therapy for Pulmonary Arterial Hypertension (2002)
    Lewis J. Rubin, David B. Badesch et al. New England Journal of Medicine
  2. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension (1996)
    Robyn J. Barst, Lewis J. Rubin et al. New England Journal of Medicine
  3. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension (2009)
    Vallerie V. McLaughlin, Stephen L. Archer et al. Journal of the American College of Cardiology
  4. Definitions and Diagnosis of Pulmonary Hypertension (2013)
    Marius M. Hoeper, Harm Jan Bogaard et al. Journal of the American College of Cardiology
  5. Predicting Survival in Pulmonary Arterial Hypertension (2010)
    Raymond L. Benza, Dave P. Miller et al. Circulation
  6. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study (2001)
    Richard N. Channick, G Simonneau et al. The Lancet
  7. Pulmonary Arterial Hypertension (2009)
    David B. Badesch, Gary E. Raskob et al. CHEST Journal
  8. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension (2009)
    Vallerie V. McLaughlin, Stephen L. Archer et al. Circulation
  9. Diagnosis and Assessment of Pulmonary Arterial Hypertension (2009)
    David B. Badesch, Hunter C. Champion et al. Journal of the American College of Cardiology
  10. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension (2008)
    Nazzareno Galiè, Horst Olschewski et al. Circulation
  11. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry (2012)
    Raymond L. Benza, Dave P. Miller et al. CHEST Journal
  12. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. (1994)
    Rubin M. Tuder, Bertron Μ. Groves et al. PubMed
  13. Medical Therapy For Pulmonary Arterial Hypertension (2004)
    David B. Badesch, Steve Abman et al. CHEST Journal
  14. Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension (1999)
    Rubin M. Tuder, Carlyne D. Cool et al. American Journal of Respiratory and Critical Care Medicine
  15. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension (2006)
    Vallerie V. McLaughlin, Ronald J. Oudiz et al. American Journal of Respiratory and Critical Care Medicine
  16. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension (2011)
    Raymond L. Benza, Mardi Gomberg‐Maitland et al. CHEST Journal
  17. Five-Year Outcomes of Patients Enrolled in the REVEAL Registry (2015)
    Harrison W. Farber, Dave P. Miller et al. CHEST Journal
  18. Sotatercept for the Treatment of Pulmonary Arterial Hypertension (2021)
    Marc Humbert, Vallerie V. McLaughlin et al. New England Journal of Medicine
  19. Diagnosis of pulmonary hypertension (2018)
    Adaani Frost, David B. Badesch et al. European Respiratory Journal
  20. Definition, classification and diagnosis of pulmonary hypertension (2024)
    Gábor Kovács, Sonja Bartolome et al. European Respiratory Journal

Immediate Impact

6 by Nobel laureates 2 from Science/Nature 171 standout
Sub-graph 1 of 10

Citing Papers

Right Ventricular Failure
2023 Standout
Systemic sclerosis
2022 Standout
274 intermediate papers

Works of David B. Badesch being referenced

Sotatercept for the Treatment of Pulmonary Arterial Hypertension
2021 Standout
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
1996 Standout
and 73 more

Author Peers

Author Last Decade Papers Cites
David B. Badesch 22563 14761 4354 162 25.1k
Nazzareno Galiè 23340 16813 4581 369 26.7k
Olivier Sitbon 23975 14275 5242 376 26.6k
Vallerie V. McLaughlin 18751 13033 3541 241 20.7k
Stuart Rich 18739 13956 3621 179 22.5k
Michael D. McGoon 21995 17784 3738 168 27.8k
Marius M. Hoeper 20306 13716 3547 401 25.0k
Robyn J. Barst 29750 20693 6415 237 33.3k
Adaani Frost 16167 10427 3181 138 18.6k
Lewis J. Rubin 30667 21340 5884 302 36.7k
David Montani 13202 6448 2517 333 15.8k

All Works

Loading papers...

Rankless by CCL
2026